Petersen Flynn & Dinsmore Inc decreased Abbvie Inc (ABBV) stake by 4.33% reported in 2017Q3 SEC filing. Petersen Flynn & Dinsmore Inc sold 9,691 shares as Abbvie Inc (ABBV)’s stock rose 6.17%. The Petersen Flynn & Dinsmore Inc holds 213,973 shares with $19.01 million value, down from 223,664 last quarter. Abbvie Inc now has $191.40B valuation. The stock increased 2.16% or $2.55 during the last trading session, reaching $120.53. About 2.81M shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since February 21, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.
Pacad Investment Ltd increased Hologic Inc (HOLX) stake by 4177.88% reported in 2017Q3 SEC filing. Pacad Investment Ltd acquired 33,423 shares as Hologic Inc (HOLX)’s stock rose 7.50%. The Pacad Investment Ltd holds 34,223 shares with $1.26M value, up from 800 last quarter. Hologic Inc now has $10.89B valuation. The stock increased 1.34% or $0.52 during the last trading session, reaching $39.39. About 870,209 shares traded. Hologic, Inc. (NASDAQ:HOLX) has risen 29.21% since February 21, 2017 and is uptrending. It has outperformed by 12.51% the S&P500.
Pacad Investment Ltd decreased Zendesk Inc (NYSE:ZEN) stake by 11,763 shares to 2,200 valued at $64,000 in 2017Q3. It also reduced Hp Inc stake by 62,414 shares and now owns 43,500 shares. Ii Vi Inc (NASDAQ:IIVI) was reduced too.
Investors sentiment decreased to 0.88 in Q3 2017. Its down 0.50, from 1.38 in 2017Q2. It turned negative, as 75 investors sold HOLX shares while 145 reduced holdings. 64 funds opened positions while 129 raised stakes. 265.54 million shares or 0.74% less from 267.53 million shares in 2017Q2 were reported. Hall Laurie J Trustee owns 2,425 shares or 0.06% of their US portfolio. 64,930 are owned by Anchor Cap Advsrs Limited Liability Company. 89,304 were accumulated by Ngam Advsr L P. Lord Abbett And Ltd Liability Com holds 0.02% of its portfolio in Hologic, Inc. (NASDAQ:HOLX) for 162,500 shares. Trillium Asset Mngmt Ltd Liability stated it has 1.02% of its portfolio in Hologic, Inc. (NASDAQ:HOLX). Raymond James Advisors has 23,185 shares for 0.01% of their portfolio. Nationwide Fund reported 0.03% stake. At Comml Bank has invested 0.26% in Hologic, Inc. (NASDAQ:HOLX). Glg Limited Company accumulated 0.12% or 51,471 shares. Martingale Asset Management Limited Partnership has 0.01% invested in Hologic, Inc. (NASDAQ:HOLX) for 13,404 shares. Sun Life Fincl reported 2,067 shares. Optimum stated it has 0.32% of its portfolio in Hologic, Inc. (NASDAQ:HOLX). Bp Pcl holds 30,000 shares. Hm Payson And accumulated 8,328 shares. Prelude Cap Mgmt Ltd Liability Corp accumulated 0.01% or 2,222 shares.
Since September 7, 2017, it had 1 insider purchase, and 3 selling transactions for $648,721 activity. $353,219 worth of stock was sold by Levy Lawrence M on Tuesday, October 10. $250,023 worth of Hologic, Inc. (NASDAQ:HOLX) was bought by Nawana Namal.
Among 18 analysts covering Hologic (NASDAQ:HOLX), 14 have Buy rating, 0 Sell and 4 Hold. Therefore 78% are positive. Hologic had 57 analyst reports since July 24, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Friday, February 9 by RBC Capital Markets. The company was maintained on Wednesday, July 5 by Needham. RBC Capital Markets maintained Hologic, Inc. (NASDAQ:HOLX) on Friday, August 11 with “Hold” rating. The stock of Hologic, Inc. (NASDAQ:HOLX) has “Buy” rating given on Friday, February 9 by Cowen & Co. The stock of Hologic, Inc. (NASDAQ:HOLX) earned “Hold” rating by Stifel Nicolaus on Friday, February 9. The rating was maintained by Canaccord Genuity with “Buy” on Thursday, June 15. The stock has “Buy” rating by Needham on Friday, June 2. On Monday, January 8 the stock rating was maintained by Piper Jaffray with “Buy”. The rating was maintained by Needham with “Buy” on Wednesday, August 23. The rating was maintained by Jefferies with “Buy” on Friday, May 26.
Since September 11, 2017, it had 0 buys, and 5 insider sales for $25.59 million activity. Gosebruch Henry O sold $1.66 million worth of stock or 18,300 shares. Another trade for 6,699 shares valued at $589,512 was sold by Michael Robert A.. $705,655 worth of stock was sold by SALEKI-GERHARDT AZITA on Monday, September 11. 87,040 AbbVie Inc. (NYSE:ABBV) shares with value of $8.57 million were sold by RICHMOND TIMOTHY J.. Schumacher Laura J sold 145,510 shares worth $14.07M.
Investors sentiment decreased to 0.85 in 2017 Q3. Its down 0.15, from 1 in 2017Q2. It turned negative, as 55 investors sold ABBV shares while 640 reduced holdings. 132 funds opened positions while 462 raised stakes. 1.06 billion shares or 1.89% more from 1.04 billion shares in 2017Q2 were reported. Massachusetts-based Beaumont Fincl Ltd Limited Liability Company has invested 0.06% in AbbVie Inc. (NYSE:ABBV). Davidson And Garrard holds 2.37% or 113,099 shares. Tortoise Investment Mgmt Limited Company accumulated 323 shares. Kornitzer Capital Mngmt Ks has invested 0.03% in AbbVie Inc. (NYSE:ABBV). Payden & Rygel has invested 1.19% in AbbVie Inc. (NYSE:ABBV). Azimuth Cap Management Limited Liability Company, Michigan-based fund reported 84,795 shares. Veritable Limited Partnership has 134,395 shares. Argyle Cap reported 12,650 shares. Brown Cap Management Ltd Liability invested in 6,348 shares or 0.01% of the stock. Royal Bancshares Of Canada owns 0.26% invested in AbbVie Inc. (NYSE:ABBV) for 6.00 million shares. New York-based Ny State Teachers Retirement Sys has invested 0.62% in AbbVie Inc. (NYSE:ABBV). Pettyjohn Wood & White reported 17,148 shares. Geller Family Office Svcs holds 0.1% or 2,300 shares. Thompson Invest Mgmt Incorporated invested 1.21% of its portfolio in AbbVie Inc. (NYSE:ABBV). Ancora Advisors Limited Liability Com invested in 0.25% or 48,974 shares.
Petersen Flynn & Dinsmore Inc increased Ligand Pharmaceuticals Inc (NASDAQ:LGND) stake by 3,744 shares to 71,413 valued at $9.72 million in 2017Q3. It also upped Trimble Inc (NASDAQ:TRMB) stake by 11,693 shares and now owns 426,451 shares. Pepsico Inc (NYSE:PEP) was raised too.